Trial intelligence / Profile preview

Preoperative Methylprednisolone in TKA

NCT02253966Phase 2Completed

Sponsor
Rigshospitalet
Start
Oct 2014
Primary completion
Mar 2016
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of methylprednisolone in osteoarthritis (OA), sponsored by Rigshospitalet. Started Oct 2014; status: completed.

02

Drugs

methylprednisolone
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT02253966.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02253966.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call